- Biostime
(1112 HK) | TP Revision
- Far
East Horizon (3360 HK) | Results Review
- Country
Garden (2007 HK) | Rating Change
- MSM
Malaysia (MSM MK) | Results Review
- Kossan
Rubber Industries (KRI MK) | Results Review
- Bumi
Armada(BAB MK) | Results Review
- Star
Publications (Malaysia) (STAR MK) | Company Visit
- MY
Banking Sector | NEUTRAL
- Boustead
Plantations (BPLANT MK) | Resuklts Review
- Gas
Malaysia (GMB MK) | Results Review
- Kuala
Lumpur Kepong (KLK MK) | Results Review
- IOI
Corporation (IOI MK) | Results Review
- AirAsia(AIRA
MK) | Rating Change
- MBM
Resources (MBM MK) | Company Update
- Bangkok
Dusit Medical Services (BGH TB) | Company Update
|
Biostime (1112 HK)
|
Sexy online story but still a
risky bet
|
Share Price: HKD33.05 | Target
Price: HKD27.30(-17%) | MCap (USD): 2.6B | ADTV (USD): 9M
|
- Maintain
SELL and new TP of HKD27.3 (16X FY15F PER from FY14/15F) on
low sales visibility, surging OPEX burden and high execution
risks. Unresolved concerns are potential: i) internal
conflicts; ii) cannibalisation; iii) external conflicts; iv)
new online strategies backfiring; and v) competition.
- POS
additions progress was respectable (+18%/48% in 6M/YoY) but
sales from maternity stores was flat YoY (despite O2O), while
data show the channel saw 8% YoY sales growth. We believe it
may have lost traction in this key channel.
- Co.
said it will not bear any O2O logistics costs for maternity
stores but we think customers particularly large ones have
limited incentive to take the online orders. Of note, 1H14 avg
points per store (proxy of SSSG) fell 10% YoY for stores operated
since 2011 or before (34% of its maternity stores).
|
Far East Horizon (3360 HK)
|
Remains in good shape
|
Share Price: HKD6.32 | Target
Price: HKD7.15(+13%) | MCap (USD): 2.7B | ADTV (USD): 3M
|
- Maintain
BUY, keep TP at HKD7.15.
- Minimize
NIM pressure and keep loan underwriting standard.
- Low
leverage helps sustain high dividend payout.
|
Country Garden (2007 HK)
|
Gearing, margin concerns; D/G to
HOLD
|
Share Price: HKD3.68 | Target
Price: HKD4.00(+9%) | MCap (USD): 9.1B | ADTV (USD): 20M
|
- D/G
to HOLD and lower TP toHKD4.0 from HKD4.6as CG�s story doesn�t look very compelling and
we cut NAV due to slower sales and lower margin assumptions.
Stronger contract sales likely in2H14 vs 1Hbutwe worry gearing
and margin recovery might take longer. Trim 2016 earnings 6%;
2014&2015 profit forecasts little changed.
- We
see the quality of 1H14 results as not high.1H14 core profit
wasCNY4.71b, up 14% YoY and ahead of Bloomberg consensus. But
interest capitalization ratio was high and core NPM dropped
3pptYoY to 12.3% in 1H14. Pre-LAT GPM down to 28.6%. We expect
2H booked GPM to be lower HoH.
- On
the surface, net gearing was fine as of June at 67%.But if we
adjust for CNY3.1b of perpetual securities treated as equity
as debt instead and adjust for some revaluation gains booked,
its net gearing would be much higher at 78%.
|
MSM Malaysia (MSM MK)
|
2Q14: Within expectations
|
Share Price: MYR4.75 | Target
Price: MYR5.00(+5%) | MCap (USD): 1.1B | ADTV (USD): 0.1M
|
- 2Q14
results are in line at 58% of our and consensus full-year
forecasts.
- Awaiting
a cessation to the issuance of new APs.
- Maintain
HOLD with an unchanged TP of MYR5.00.
|
Kossan Rubber Industries (KRI MK)
|
Stronger growth ahead
|
Share Price: MYR3.97 | Target
Price: MYR5.00(+26%) | MCap (USD): 804M | ADTV (USD): 1M
|
- Slight
earnings dip in 2Q14 as water rationing affected production.
- Expect
stronger earnings in 2H14 on new capacities.
- Maintain
BUY and TP of MYR5.00 (17x FY14 PER).
- (Full
report will be out soon)
|
Bumi Armada(BAB MK)
|
Results on track
|
Share Price: MYR3.33 | Target
Price: MYR4.55 (+37%) | MCap (USD): 3.1B | ADTV (USD): 2.8M
|
- 1H14
earnings are on track to meet our full-year estimates but are
significantly below consensus.
- Job
wins and tender pipelines are healthy; execution is key.
Rights and bonus issues to conclude soon.
- Maintain
BUY; SOP-based TP of MYR4.55 is under review.
|
Star Publications (Malaysia)
(STAR MK)
|
Already in the price
|
Share Price: MYR2.77 | Target
Price: MYR2.89(+4%) | MCap (USD): 646M | ADTV (USD): 0.4M
|
- The
great 2Q14 results may be short-lived.
- Nonetheless,
we raise DPS estimate by 20% to 18 sen p.a..
- Maintain
HOLD call but raise TP by 16% to MYR2.89.
|
MY Banking Sector
|
Deposit competition still intense
|
Sector update
|
- Positively,
rate competition on the lending side appears to have eased.
Conversely, deposit competition is still intense.
- Still
room for NIMs to expand, but any rebound is likely to be mild.
- NEUTRAL
on the sector, BUY picks continue to be AFG, AMMB, HL Bank and
HL Financial Group.
|
Boustead Plantations (BPLANT MK)
|
Downside capped by its land value
|
Share Price: MYR1.58 | Target
Price: MYR2.16(+37%) | MCap (USD): 816M | ADTV (USD): 3M
|
- 2Q14
results were below expectations.
- Share
price downside is supported by its MYR3.08/sh RNAV, backed by
its strategic land that has development potential.
- Maintain
BUY with a SOP-TP of MYR2.16.
|
Gas Malaysia (GMB MK)
|
Potential dividend bummer?
|
Share Price: MYR3.43 | Target
Price: MYR3.80(+11%) | MCap (USD): 1.4B | ADTV (USD): 0.6M
|
- 1H14
net profit was in line at 50% of our full-year forecast, and
47% of consensus.
- A
lower interim DPS of 5sen was declared (6 sen in 1H13),
placing into doubt a 100% payout in 2014.
- Maintain
HOLD, TP unchanged at MYR3.80.
|
Kuala Lumpur Kepong (KLK MK)
|
A traditionally weak 3Q
|
Share Price: MYR23.86 | Target
Price: MYR23.20(-3%) | MCap (USD): 8.1B | ADTV (USD): 5M
|
- 3QFY9/14
results within our and street estimates.
- Expect
stronger QoQ results ahead on improved FFB output, contracted
forward sales, and higher downstream margins.
- Maintain
HOLD with a revised TP of MYR23.20 as we trim our FY9/14-15
earnings forecasts by 2.8%/3.8%.
|
IOI Corporation (IOI MK)
|
Pricey on forward earnings
|
Share Price: MYR5.00 | Target
Price: MYR3.97(-21%) | MCap (USD): 10.2B | ADTV (USD): 8M
|
- FY6/14
results was within our and street estimates.
- IOI
is the most expensive plantation stock regionally at EV/ha of
MYR163k, 26x FY6/15 PER. We forecast profit to fall 20%.
- IOI
risks being taken off the Shariah list this November review.
Maintain SELL.
|
AirAsia(AIRA MK)
|
It was a mirage, 2014 will be
tough
|
Share Price: MYR2.38 | Target
Price: MYR2.55 (+7%) | MCap (USD): 2.1B | ADTV (USD): 5.2M
|
- 2Q14
core net income of MYR25.4m (-77% YoY, -80% QoQ) was below
expectations; our FY14 earnings cut by 28%.
- Yields
were lower and unit costs were higher than expected.
- Cut
to HOLD (from BUY) with a lower target price of MYR2.55 (from
MYR2.65) as we also rollover to FY15 as base year.
|
MBM Resources (MBM MK)
|
Excitement from Perodua
|
Share Price: MYR2.78 | Target
Price: MYR3.42 (+23%) | MCap (USD): 0.3B | ADTV (USD): 0.2M
|
- Fundamentals
remain intact with improving earnings outlook.
- Trim
FY15 earnings by 5% on further delays in securing orders by
OMI�s alloy wheel plant.
- Maintain
BUY but shave our TP to MYR3.42 on unchanged 9x FY15 PER.
Compelling valuations at 7.3x FY15 PER.
|
Bangkok Dusit Medical Services
(BGH TB)
|
Best Guarded Hospital
|
Share Price: THB18.10 | Target
Price: THB22.00(+22%) | MCap (USD): 8.8B | ADTV (USD): 22M
|
- Targets
to increase its portfolio from 34 to 50 hospitals by the end
of 2015. There are nine greenfields and seven M&A
hospitals in the pipeline with total investment of THB19-22b.
- Acquisition
of Save Drug Center for THB380m will create synergy and value over
long term. Management sticks with 11-13% growth forecast. Sets
22-23% EBITDA margin and targets net profit margin of 12%.
- Maintain
BUY with DCF-based TP of THB22, implying 37x PER, 6x P/BV and
1.3x PEG for FY15F. Medium to long-term outlook intact. M&A
is a short-term catalyst.
- (Full
report will be out soon)
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.